论文信息 - Molecular Response to First Line Imatinib Therapy Is Predictive for Long Term Event Free Survival in Patients with Chronic Phase Chronic Myelogenous Leukemia – An Interim Analysis of the Randomized German CML Study IV - 字舞流文

Molecular Response to First Line Imatinib Therapy Is Predictive for Long Term Event Free Survival in Patients with Chronic Phase Chronic Myelogenous Leukemia – An Interim Analysis of the Randomized German CML Study IV

Martin C. Müller | J. Hasford | S. Schnittger | A. Gratwohl | A. Tobler | D. Hossfeld | T. Fischer | P. Erben | G. Ehninger | R. Hehlmann | A. Hochhaus | S. Krause | C. Nerl | B. Hanfstein | A. Leitner | H. Kolb | H. Pralle | S. Saussele | M. Lauseker | M. Pfirrmann | U. Proetel | Hans Pralle | Alois Gratwohl